Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 5Withdrawn 2Terminated 2Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 35INDUSTRY 5FED 2NIH 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Neoplasms 1905Breast Neoplasms 1426Carcinoma, Non-Small-Cell Lung 1179Prostatic Neoplasms 740Colorectal Neoplasms 686Neoplasm Metastasis 624Multiple Myeloma 548Melanoma 529Ovarian Neoplasms 456Lung Neoplasms 447Lymphoma, Non-Hodgkin 385Recurrence 374Lymphoma 374Leukemia, Myeloid, Acute 370Pancreatic Neoplasms 358Carcinoma, Renal Cell 339Carcinoma, Hepatocellular 286Stomach Neoplasms 281Leukemia, Lymphocytic, Chronic, B-Cell 268Lymphoma, Follicular 254Head and Neck Neoplasms 246Glioblastoma 220Leukemia 215Small Cell Lung Carcinoma 183Lymphoma, Large B-Cell, Diffuse 183Squamous Cell Carcinoma of Head and Neck 181Urinary Bladder Neoplasms 175Carcinoma 175Uterine Cervical Neoplasms 174Advanced Solid Tumors 161

Interventions

YF 476 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Gastroesophageal Reflux × Clear all
NCT02597712 2021-04-12

YF476 in Barrett's Esophagus

Trio Medicines Ltd.

Phase 2 Completed
27 enrolled 15 charts
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux

NCT00885469 2019-07-31

MA-76

Medtronic - MITG

Completed
101 enrolled
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux

NCT02395471 2019-07-30

CASEII

Medtronic - MITG

Phase NA Completed
191 enrolled 15 charts
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux

NCT03859557 2019-03-01

The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy

CDx Diagnostics

Completed
1,032 enrolled
Gastrointestinal

Barrett Esophagus, Esophageal Diseases, Gastroesophageal Reflux

NCT02159898 2018-06-07

EndoMAXX Endoluminal Valve Technology (EVT) Compared to EndoMAXX

Merit Medical Systems, Inc.

Phase NA Completed
60 enrolled 9 charts
Gastrointestinal

Deglutition Disorders, Esophageal Neoplasms, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡